
Xialla Anchored Constriction Ring: Published Overview
Stay up to date.
This article summarizes a perspective piece on Xialla published in the International Journal of Impotence Research. The original paper is available at Nature / IJIR. A related Knowledge Center note is Xialla Featured in the International Journal of Impotence Research.
What the perspective covers
Urology has seen growth in devices aimed at sexual dysfunction. Xialla is discussed in that context as an FDA-registered Class II silicone constriction ring designed for erectile dysfunction related to venous leak (veno-occlusive dysfunction).
Venous leak — incomplete retention of blood in the penis during erection — is a common contributor to ED.
In the perspective, Dr. Faysal Yafi (University of California Irvine) is cited regarding Xialla’s role among devices aimed at venous-leak ED. That is an expert comment in a perspective article, not a guideline endorsement.
Design differences from unanchored rings
Unlike many conventional rings that are difficult to place without an existing erection, Xialla can be applied when the penis is erect or flaccid. An anchoring strap and adhesive pad are intended to keep the ring at the base of the penis during intercourse, so venous compression does not depend solely on circumferential tightness. Soft silicone and a smooth finish are part of the comfort design.
Application, in brief: place the adhesive pad on the lower back, fit the ring at the base of the penis, pass the loop around the scrotum, and secure the band to the pad. Full instructions are at xialla.com/pages/instructions. Maximum continuous wear is 30 minutes; remove before sleep and if numbness, coldness, discoloration, or pain occurs. See using a constriction device safely.
Evidence and use with other therapies
Published clinical work on Xialla includes small series (for example Bella et al., 14 of 21 patients with improved erectile function in a 2016 presentation). These are small studies; larger trials are still needed. User ratings on Trustpilot have been reported in the mid-4 range out of 5 across hundreds of reviews.
Xialla can be used alone or with therapies that increase inflow — oral PDE5 inhibitors, injections, or vacuum pumps — because it acts on retention rather than replacing those mechanisms. See Xialla and ED medication and Using Xialla with ED pumps.
What this article does not claim
A perspective article and small trials support further study and clinical interest. They do not by themselves establish superiority over every other ED option, reverse ED as a disease process, or replace shared decision-making with a clinician.
If you have questions about anything in this article, write to us at hello@xialla.com. We read and answer every message.
This article is for general education and is not medical advice. Consult a qualified healthcare provider about your individual situation.


